Dimensional Fund Advisors

Dimensional Fund Advisors Portfolio holdings

AUM $432B
 

Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.

This Quarter Return
+1.83%
1 Year Return
+19.15%
3 Year Return
+80.48%
5 Year Return
+182.76%
10 Year Return
+378.45%
AUM
$416B
AUM Growth
+$416B
Cap. Flow
+$7.22B
Cap. Flow %
1.73%
Top 10 Hldgs %
16.07%
Holding
3,410
New
61
Increased
1,890
Reduced
1,266
Closed
71

Sector Composition

1 Technology 20.48%
2 Financials 18.31%
3 Industrials 12.31%
4 Consumer Discretionary 10.89%
5 Healthcare 9.53%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
LCTX icon
3326
Lineage Cell Therapeutics
LCTX
$279M
$20.3K ﹤0.01%
40,449
AYTU icon
3327
AYTU BioPharma
AYTU
$21.1M
$18.2K ﹤0.01%
10,926
-10,906
-50% -$18.2K
RPTX icon
3328
Repare Therapeutics
RPTX
$73M
$17.4K ﹤0.01%
13,265
SY
3329
So-Young International
SY
$376M
$16.2K ﹤0.01%
19,737
CMPX icon
3330
Compass Therapeutics
CMPX
$483M
$16.1K ﹤0.01%
11,117
REI icon
3331
Ring Energy
REI
$219M
$15.5K ﹤0.01%
11,409
-10,248
-47% -$13.9K
NDLS icon
3332
Noodles & Co
NDLS
$33.1M
$15.3K ﹤0.01%
26,504
-122,093
-82% -$70.7K
PRLD icon
3333
Prelude Therapeutics
PRLD
$68.5M
$13.9K ﹤0.01%
10,981
-18,101
-62% -$22.9K
SPRO icon
3334
Spero Therapeutics
SPRO
$116M
$10.3K ﹤0.01%
10,003
PED icon
3335
PEDEVCO
PED
$55.9M
$9.88K ﹤0.01%
12,700
VFF icon
3336
Village Farms International
VFF
$306M
$9.55K ﹤0.01%
12,380
LYEL icon
3337
Lyell Immunopharma
LYEL
$213M
$8.62K ﹤0.01%
13,463
-3,138
-19% -$2.01K
IVVD icon
3338
Invivyd
IVVD
$216M
$7.71K ﹤0.01%
17,327
RLMD icon
3339
Relmada Therapeutics
RLMD
$47.1M
$7.5K ﹤0.01%
14,428
-58,976
-80% -$30.7K
AFRI icon
3340
Forafric Global
AFRI
$234M
-11,879
Closed -$135K
AHT
3341
Ashford Hospitality Trust
AHT
$36.7M
-26,910
Closed -$20.1K
ATHA icon
3342
Athira Pharma
ATHA
$15.3M
-321,447
Closed -$143K
JBIO
3343
Jade Biosciences, Inc. Common Stock
JBIO
$258M
-10,579
Closed -$22.1K
CMCT
3344
Creative Media & Community Trust
CMCT
$4.73M
-70,227
Closed -$34.5K
CODX icon
3345
Co-Diagnostics
CODX
$12.3M
-10,542
Closed -$13.2K
CPSH icon
3346
CPS Technologies
CPSH
$50.1M
-16,637
Closed -$23.6K
CRNX icon
3347
Crinetics Pharmaceuticals
CRNX
$2.92B
-392,196
Closed -$20M
CUE icon
3348
Cue Biopharma
CUE
$60M
-14,575
Closed -$10.9K
CVM icon
3349
CEL-SCI Corp
CVM
$71.8M
-16,484
Closed -$17.5K
DCOR icon
3350
Dimensional US Core Equity 1 ETF
DCOR
$2.03B
-60,000
Closed -$3.8M